A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Opioid DependenceOpioid Related DisordersCocaine Dependence
Interventions
DRUG

RBP-8000 100 mg

RBP-8000 100 mg administered in the vein on either study day 3 or 6. There is a 72-hour washout between Days 3 and 6

DRUG

Placebo

IV infusion of Placebo administered 1 minute after cocaine infusion on either day 3 or 6.

DRUG

Cocaine

50 mg intravenous (IV) dose of cocaine administered over 10 minutes on Days 1, 3 and 6.

DRUG

RBP-8000 200 mg

RBP-8000 200 mg administered in the vein on either study day 3 or 6. There is a 72-hour washout between Days 3 and 6

Trial Locations (1)

66212

Vince and Associates Clinical Research, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Indivior Inc.

INDUSTRY

NCT01846481 - A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse | Biotech Hunter | Biotech Hunter